Emma S. Luckett
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.
Journal: Alzheimer's research & therapy
Published: February 05, 2026
Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 29, 2026
Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease.
Journal: Communications medicine
Published: December 23, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: August 14, 2025
GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.
Journal: Nature communications
Published: June 23, 2025
Polygenic pathways shape white matter vulnerability to Alzheimer's disease-related pathophysiological changes.
Journal: Alzheimer's research & therapy
Published: June 12, 2025
GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagy.
Journal: Research square
Published: June 05, 2025
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 09, 2025
Harmonizing genotype array data to understand genetic risk for brain amyloid burden in the AMYPAD PNHS Consortium.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 30, 2025
Amyloid-PET imaging predicts functional decline in clinically normal individuals.
Journal: Alzheimer's research & therapy
Published: February 01, 2024
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.
Journal: Brain communications
Published: November 17, 2023
Last Updated: 09/26/2026